Results 301 to 310 of about 496,062 (355)

A systematic review and meta-analysis on how different dexamethasone administration regimes impact total joint arthroplasty outcomes. [PDF]

Front Pharmacol
Wang C, Luo C, Tang X, Luo L, Zeng Y, Zhang Y, Wang X.   +6 more
europepmc   +1 more source

Epigenetic reprogramming in multiple myeloma—Challenges and opportunities

International Journal of Cancer, EarlyView.
Abstract In cancer, mutational processes act in concert with epigenetic reprogramming to endow malignant cells with hallmark properties that underpin tumorigenesis. Compared with the relatively rigid and slow processes of genetic evolution, the plastic nature of chromatin enables cells to adapt to a changing environment more rapidly.
Subhasree Kumar, Lev M. Kats, Emily Gruber   +2 more
wiley   +1 more source

Pharmacokinetics of dexamethasone in tuberculosis meningitis

Calderin JM, Resendiz-Galvan JE, Abdelgawad N, Davis A, Stek C, Wiesner L, Meintjes G, Wilkinson RJ, Denti P, Wasserman S.   +9 more
europepmc   +1 more source

Exploring pharmacological strategies in the management of ARDS: Efficacy, limitations, and future directions. [PDF]

J Crit Care Med (Targu Mures)
Almuntashiri S.
europepmc   +1 more source

Cancer in pregnancy: FIGO Best practice advice and narrative review

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Cancer during pregnancy is relatively rare. The incidence is underestimated due to the lack of international registries covering both high‐income and low‐ and middle‐income countries, and is expected to rise with increasing maternal age and increasing global adoption of cell‐free DNA testing for aneuploidy.
Surabhi Nanda, Melanie Nana, Long Nguyen‐Hoang, Sumaiya Adam, Fionnuala McAuliffe, Lina Bergman, Sarikapan Wilailak, Orla McNally, Cynthia V. Maxwell, Nikhil Purandare, Bo Jacobsson, Virna P. Medina, Anil Kapur, Titus Beyuo, Francisco Ruiloba, Ernesto Castelazo, Graeme N. Smith, Sharleen L. O'Reilly, Patrick O'Brien, Mark Hanson, Mary L. Rosser, Claudio Sosa, Valerie Guinto, Jonathan Berek, Catherine Nelson‐Piercy, Frédéric Amant, Liona Poon, on behalf of the FIGO Committee on the Impact of Pregnancy on Long‐term Health, FIGO Committee on Women's Cancer, and the FIGO Division of Maternal and Newborn Health   +29 more
wiley   +1 more source

Cellulose-Based Scaffolds with Prolonged Dexamethasone Release for Bone Tissue Engineering. [PDF]

Molecules
Liesienė J, Baniukaitiene O, Minseviciene I.   +2 more
europepmc   +1 more source

Antenatal dexamethasone for late preterm delivery: Rate of complete course and neonatal outcomes

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This retrospective cohort study aimed to assess the rate of complete dexamethasone administration among late preterm deliveries and its impact on neonatal outcomes. Methods We reviewed medical records of 1500 late preterm deliveries (gestational age 34–36 + 6 weeks) between January 2018 and December 2020, analyzing baseline ...
Piyamon Srisakulpanich, Pattarawalai Talungchit, Tachjaree Panchalee, Chutima Yaiyiam   +3 more
wiley   +1 more source

A Single Perioperative Dose of Dexamethasone Is Not Associated With an Increased Risk of Infection in Patients With Hip or Knee Osteoarthritis Considered for Elective Primary Total Hip or Total Knee Arthroplasty. [PDF]

Arthroplast Today
Roškar S, Levašič V, Blas M, Kovač S.   +3 more
europepmc   +1 more source

Metagenomic Next‐Generation Sequencing for Diagnosing Challenging Disseminated Tuberculosis: A Case Report

iLABMED, EarlyView.
This paper presents a case of hematogenous disseminated pulmonary tuberculosis diagnosed with the aid of metagenomic next‐generation sequencing technology. The tuberculosis infection involves both lungs, the left sacroiliac joint, and the brain, with imaging demonstrating marked improvement of the lesions following anti‐tuberculosis therapy. This study
Zhipeng Zhao, Rui Li, Leping Zhong, Runqing Li   +3 more
wiley   +1 more source

Treatment Patterns, Goals, and Decision-Making Criteria for Second- and Third-Line Therapies for Multiple Myeloma in Germany. [PDF]

Adv Ther
Steinmetz HT, Ertel F, Brinkmann B, Houghton K, Nham T, Flossmann C.   +5 more
europepmc   +1 more source